{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:12:47Z","timestamp":1787505167711,"version":"build-2736575974"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003329","name":"MINECO","doi-asserted-by":"publisher","award":["SAF2009\/08460"],"award-info":[{"award-number":["SAF2009\/08460"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003329","name":"MINECO","doi-asserted-by":"publisher","award":["SAF2013\/48586R"],"award-info":[{"award-number":["SAF2013\/48586R"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003086","name":"Basque Government","doi-asserted-by":"publisher","award":["IT616-13"],"award-info":[{"award-number":["IT616-13"]}],"id":[{"id":"10.13039\/501100003086","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003086","name":"Basque Government","doi-asserted-by":"publisher","award":["S-PE13UN006"],"award-info":[{"award-number":["S-PE13UN006"]}],"id":[{"id":"10.13039\/501100003086","id-type":"DOI","asserted-by":"publisher"}]},{"name":"ERD Funds"},{"DOI":"10.13039\/501100006751","name":"CIBERSAM","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006751","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Spanish MECD"},{"name":"University of the Basque Country UPV\/EHU"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.neuropharm.2018.02.020","type":"journal-article","created":{"date-parts":[[2018,2,22]],"date-time":"2018-02-22T10:31:23Z","timestamp":1519295483000},"page":"491-502","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Serotonin 5-HT3 receptor antagonism potentiates the antidepressant activity of citalopram"],"prefix":"10.1016","volume":"133","author":[{"given":"Blanca","family":"Perez-Palomar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Mollinedo-Gajate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Berrocoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Javier","family":"Meana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8188-874X","authenticated-orcid":false,"given":"Jorge E.","family":"Ortega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.neuropharm.2018.02.020_bib1","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0165-6147(00)01682-5","article-title":"How does pindolol improve antidepressant action?","volume":"22","author":"Artigas","year":"2001","journal-title":"Trends Pharmacol. Sci."},{"issue":"9","key":"10.1016\/j.neuropharm.2018.02.020_bib2","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/S0166-2236(96)10037-0","article-title":"Acceleration of the effect of selected antidepressant drugs in major depression by 5-HT1A antagonists","volume":"19","author":"Artigas","year":"1996","journal-title":"Trends Neurosci."},{"issue":"10","key":"10.1016\/j.neuropharm.2018.02.020_bib3","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1517\/14656566.2011.585459","article-title":"Review of the use of mirtazapine in the treatment of depression","volume":"12","author":"Benjamin","year":"2011","journal-title":"Expet Opin. Pharmacother."},{"issue":"3","key":"10.1016\/j.neuropharm.2018.02.020_bib4","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0924-977X(00)00069-9","article-title":"Effects of the co-administration of mirtazapine and paroxetine on serotonergic neurotransmission in the rat brain","volume":"10","author":"Besson","year":"2000","journal-title":"Eur. Neuropsychopharmacol"},{"issue":"5","key":"10.1016\/j.neuropharm.2018.02.020_bib5","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1017\/S1461145712001058","article-title":"The rapid recovery of 5-HT cell firing induced by the antidepressant vortioxetine involves 5-HT(3) receptor antagonism","volume":"16","author":"Betry","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2018.02.020_bib6","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.pbb.2015.02.011","article-title":"A\u00a05-HT3 receptor antagonist potentiates the behavioral, neurochemical and electrophysiological actions of an SSRI antidepressant","volume":"131","author":"Betry","year":"2015","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"1","key":"10.1016\/j.neuropharm.2018.02.020_bib7","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0022-3565(25)23184-6","article-title":"Serotonergic modulation of the release of endogenous norepinephrine from rat hypothalamic slices","volume":"256","author":"Blandina","year":"1991","journal-title":"J.\u00a0Pharmacol. Exp. Therapeut."},{"issue":"3","key":"10.1016\/j.neuropharm.2018.02.020_bib8","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1176\/appi.ajp.2009.09020186","article-title":"Combination of antidepressant medications from treatment initiation for major depressive disorder: a double-blind randomized study","volume":"167","author":"Blier","year":"2010","journal-title":"Am. J. Psychiatr."},{"issue":"4","key":"10.1016\/j.neuropharm.2018.02.020_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001434","article-title":"Grand challenges in global mental health: integration in research, policy, and practice","volume":"10","author":"Collins","year":"2013","journal-title":"PLoS Med."},{"issue":"1","key":"10.1016\/j.neuropharm.2018.02.020_bib10","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2165\/11587620-000000000-00000","article-title":"If at first you don't succeed: a review of the evidence for antidepressant augmentation, combination and switching strategies","volume":"71","author":"Connolly","year":"2011","journal-title":"Drugs"},{"key":"10.1016\/j.neuropharm.2018.02.020_bib11","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.pnpbp.2013.05.002","article-title":"A\u00a0proposal for refining the forced swim test in swiss mice","volume":"45","author":"Costa","year":"2013","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.neuropharm.2018.02.020_bib12","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/S0022-3565(24)39013-5","article-title":"Antidepressant-like behavioral effects mediated by 5-hydroxytryptamine(2C) receptors","volume":"295","author":"Cryan","year":"2000","journal-title":"J.\u00a0Pharmacol. Exp. Therapeut."},{"issue":"3","key":"10.1016\/j.neuropharm.2018.02.020_bib13","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0014-2999(01)01628-4","article-title":"Noradrenergic lesions differentially alter the antidepressant-like effects of reboxetine in a modified forced swim test","volume":"436","author":"Cryan","year":"2002","journal-title":"Eur. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.neuropharm.2018.02.020_bib14","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0165-6147(02)02017-5","article-title":"Assessing antidepressant activity in rodents: recent developments and future needs","volume":"23","author":"Cryan","year":"2002","journal-title":"Trends Pharmacol. Sci."},{"issue":"2","key":"10.1016\/j.neuropharm.2018.02.020_bib15","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/S0022-3565(25)12943-1","article-title":"Differences in modulation of noradrenergic and serotonergic transmission by the alpha-2 adrenoceptor antagonists, mirtazapine, mianserin and idazoxan","volume":"277","author":"de Boer","year":"1996","journal-title":"J.\u00a0Pharmacol. Exp. Therapeut."},{"issue":"1","key":"10.1016\/j.neuropharm.2018.02.020_bib16","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/BF02245592","article-title":"Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants","volume":"121","author":"Detke","year":"1995","journal-title":"Psychopharmacology (Berl)"},{"issue":"1\u20133","key":"10.1016\/j.neuropharm.2018.02.020_bib17","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ejphar.2004.01.018","article-title":"Mirtazapine-induced corelease of dopamine and noradrenaline from noradrenergic neurons in the medial prefrontal and occipital cortex","volume":"487","author":"Devoto","year":"2004","journal-title":"Eur. J. Pharmacol."},{"issue":"7","key":"10.1016\/j.neuropharm.2018.02.020_bib18","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1038\/sj.npp.1300433","article-title":"Effects of chronic fluoxetine in animal models of anxiety and depression","volume":"29","author":"Dulawa","year":"2004","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.neuropharm.2018.02.020_bib19","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00213-013-3112-y","article-title":"Involvement of serotonin 5-HT3 receptors in the modulation of noradrenergic transmission by serotonin reuptake inhibitors: a microdialysis study in rat brain","volume":"229","author":"Fernandez-Pastor","year":"2013","journal-title":"Psychopharmacology (Berl)"},{"issue":"3","key":"10.1016\/j.neuropharm.2018.02.020_bib20","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1007\/s00213-005-2181-y","article-title":"Characterization of noradrenaline release in the locus coeruleus of freely moving awake rats by in\u00a0vivo microdialysis","volume":"180","author":"Fernandez-Pastor","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2018.02.020_bib21","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.neuropharm.2016.11.025","article-title":"Chronic citalopram administration desensitizes prefrontal cortex but not somatodendritic alpha2-adrenoceptors in rat brain","volume":"114","author":"Fernandez-Pastor","year":"2017","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.neuropharm.2018.02.020_bib22","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/BF00512929","article-title":"Serotonin (5-HT) enhances hippocampal noradrenaline (NA) release: evidence for facilitatory 5-HT receptors within the CNS","volume":"333","author":"Feuerstein","year":"1986","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"issue":"1","key":"10.1016\/j.neuropharm.2018.02.020_bib23","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0006-8993(91)90242-N","article-title":"Localization of 5-HT3 receptors in the rat brain using [3H]LY278584","volume":"553","author":"Gehlert","year":"1991","journal-title":"Brain Res."},{"issue":"1\u20132","key":"10.1016\/j.neuropharm.2018.02.020_bib24","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ejphar.2005.05.033","article-title":"Alpha(2)-adrenoceptor involvement in the in\u00a0vitro inhibitory effect of citalopram on a subpopulation of rat locus coeruleus neurons","volume":"517","author":"Grandoso","year":"2005","journal-title":"Eur. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.neuropharm.2018.02.020_bib25","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/sj.bjp.0700968","article-title":"Modulation of the firing activity of noradrenergic neurones in the rat locus coeruleus by the 5-hydroxtryptamine system","volume":"120","author":"Haddjeri","year":"1997","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.neuropharm.2018.02.020_bib26","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/sj.npp.1301399","article-title":"Behavioral effects of chronic fluoxetine in BALB\/cJ mice do not require adult hippocampal neurogenesis or the serotonin 1A receptor","volume":"33","author":"Holick","year":"2008","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.neuropharm.2018.02.020_bib27","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0306-4522(97)00372-2","article-title":"Potent excitatory influence of prefrontal cortex activity on noradrenergic locus coeruleus neurons","volume":"83","author":"Jodo","year":"1998","journal-title":"Neuroscience"},{"issue":"23","key":"10.1016\/j.neuropharm.2018.02.020_bib28","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1001\/jama.289.23.3095","article-title":"The epidemiology of major depressive disorder: Results from the national comorbidity survey replication (NCS-R)","volume":"289","author":"Kessler","year":"2003","journal-title":"Jama"},{"issue":"1\u20132","key":"10.1016\/j.neuropharm.2018.02.020_bib29","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0006-8993(93)91674-H","article-title":"5-HT3 receptors in the rat central nervous system are mainly located on nerve fibres and terminals","volume":"612","author":"Kidd","year":"1993","journal-title":"Brain Res."},{"issue":"4","key":"10.1016\/j.neuropharm.2018.02.020_bib30","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/syn.890100402","article-title":"Quantitative autoradiographic mapping of 5-HT3 receptors in the rat CNS using [125I]iodo-zacopride and [3H]zacopride as radioligands","volume":"10","author":"Laporte","year":"1992","journal-title":"Synapse"},{"issue":"2","key":"10.1016\/j.neuropharm.2018.02.020_bib31","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1046\/j.1471-4159.1998.71020790.x","article-title":"Somatodendritic alpha2-adrenoceptors in the locus coeruleus are involved in the in\u00a0vivo modulation of cortical noradrenaline release by the antidepressant desipramine","volume":"71","author":"Mateo","year":"1998","journal-title":"J.\u00a0Neurochem."},{"issue":"11","key":"10.1016\/j.neuropharm.2018.02.020_bib32","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1016\/S0028-3908(00)00041-1","article-title":"Inhibition of 5-hydroxytryptamine reuptake by the antidepressant citalopram in the locus coeruleus modulates the rat brain noradrenergic transmission in\u00a0vivo","volume":"39","author":"Mateo","year":"2000","journal-title":"Neuropharmacology"},{"issue":"11","key":"10.1016\/j.neuropharm.2018.02.020_bib33","doi-asserted-by":"crossref","first-page":"e442","DOI":"10.1371\/journal.pmed.0030442","article-title":"Projections of global mortality and burden of disease from 2002 to 2030","volume":"3","author":"Mathers","year":"2006","journal-title":"PLoS Med."},{"issue":"3","key":"10.1016\/j.neuropharm.2018.02.020_bib34","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/S0022-3565(25)24527-X","article-title":"Modulation of norepinephrine release by serotonergic receptors in the rat hippocampus as measured by in\u00a0vivo microdialysis","volume":"272","author":"Matsumoto","year":"1995","journal-title":"J.\u00a0Pharmacol. Exp. Therapeut."},{"issue":"10","key":"10.1016\/j.neuropharm.2018.02.020_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ijnp\/pyw055","article-title":"The effects of vortioxetine on cognitive function in patients with major depressive disorder: a meta-analysis of three randomized controlled trials","volume":"19","author":"McIntyre","year":"2016","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"6\u20137","key":"10.1016\/j.neuropharm.2018.02.020_bib36","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.neuropharm.2009.03.004","article-title":"Alpha(2)-adrenoceptors mediate the acute inhibitory effect of fluoxetine on locus coeruleus noradrenergic neurons","volume":"56","author":"Miguelez","year":"2009","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.neuropharm.2018.02.020_bib37","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1046\/j.1460-9568.2000.00982.x","article-title":"Mirtazapine enhances frontocortical dopaminergic and corticolimbic adrenergic, but not serotonergic, transmission by blockade of alpha2-adrenergic and serotonin2C receptors: a comparison with citalopram","volume":"12","author":"Millan","year":"2000","journal-title":"Eur. J. Neurosci."},{"issue":"1","key":"10.1016\/j.neuropharm.2018.02.020_bib38","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0014-2999(94)90272-0","article-title":"Effect of long-term administration of antidepressant drugs on the 5-HT3 receptors that enhance the electrically evoked release of [3H]noradrenaline in the rat hippocampus","volume":"271","author":"Mongeau","year":"1994","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.neuropharm.2018.02.020_bib39","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0014-2999(94)90552-5","article-title":"Activation of 5-HT3 receptors enhances the electrically evoked release of [3H]noradrenaline in rat brain limbic structures","volume":"256","author":"Mongeau","year":"1994","journal-title":"Eur. J. Pharmacol."},{"issue":"9","key":"10.1016\/j.neuropharm.2018.02.020_bib40","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1523\/JNEUROSCI.17-09-03157.1997","article-title":"The 5-HT3 receptor is present in different subpopulations of GABAergic neurons in the rat telencephalon","volume":"17","author":"Morales","year":"1997","journal-title":"J.\u00a0Neurosci."},{"issue":"3","key":"10.1016\/j.neuropharm.2018.02.020_bib41","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1124\/jpet.111.189068","article-title":"Pharmacological effects of lu AA21004: a novel multimodal compound for the treatment of major depressive disorder","volume":"340","author":"Mork","year":"2012","journal-title":"J.\u00a0Pharmacol. Exp. Therapeut."},{"issue":"1","key":"10.1016\/j.neuropharm.2018.02.020_bib42","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1476-5381.2012.01850.x","article-title":"Blockade of the high-affinity noradrenaline transporter (NET) by the selective 5-HT reuptake inhibitor escitalopram: an in\u00a0vivo microdialysis study in mice","volume":"168","author":"Nguyen","year":"2013","journal-title":"Br. J. Pharmacol."},{"issue":"7 Suppl.\u00a0l","key":"10.1016\/j.neuropharm.2018.02.020_bib43","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/(SICI)1520-6394(1998)7:1+<7::AID-DA3>3.0.CO;2-2","article-title":"Efficacy of mirtazapine in clinically relevant subgroups of depressed patients","volume":"1","author":"Nutt","year":"1998","journal-title":"Depress. Anxiety"},{"issue":"8","key":"10.1016\/j.neuropharm.2018.02.020_bib44","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1016\/j.neuropharm.2012.02.018","article-title":"Regulation of central noradrenergic activity by 5-HT(3) receptors located in the locus coeruleus of the rat","volume":"62","author":"Ortega","year":"2012","journal-title":"Neuropharmacology"},{"issue":"11","key":"10.1016\/j.neuropharm.2018.02.020_bib45","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.euroneuro.2010.07.008","article-title":"In\u00a0vivo potentiation of reboxetine and citalopram effect on extracellular noradrenaline in rat brain by alpha2-adrenoceptor antagonism","volume":"20","author":"Ortega","year":"2010","journal-title":"Eur. Neuropsychopharmacol"},{"issue":"1\u20133","key":"10.1016\/j.neuropharm.2018.02.020_bib46","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ejphar.2013.03.043","article-title":"Additive effect of rimonabant and citalopram on extracellular serotonin levels monitored with in\u00a0vivo microdialysis in rat brain","volume":"709","author":"Ortega","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.02.020_bib47","doi-asserted-by":"crossref","first-page":"16065","DOI":"10.1038\/nrdp.2016.65","article-title":"Major depressive disorder","volume":"2","author":"Otte","year":"2016","journal-title":"Nat Rev Dis Primers"},{"issue":"1\u20132","key":"10.1016\/j.neuropharm.2018.02.020_bib48","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0022-510X(96)00211-0","article-title":"Autoradiographic distribution of [3H]-(S)-zacopride-labelled 5-HT3 receptors in human brain","volume":"144","author":"Parker","year":"1996","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1016\/j.neuropharm.2018.02.020_bib49","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1986"},{"issue":"5604","key":"10.1016\/j.neuropharm.2018.02.020_bib50","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/266730a0","article-title":"Depression: a new animal model sensitive to antidepressant treatments","volume":"266","author":"Porsolt","year":"1977","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.neuropharm.2018.02.020_bib51","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1093\/cercor\/bhh097","article-title":"In\u00a0vivo excitation of GABA interneurons in the medial prefrontal cortex through 5-HT3 receptors","volume":"14","author":"Puig","year":"2004","journal-title":"Cerebr. Cortex"},{"issue":"4","key":"10.1016\/j.neuropharm.2018.02.020_bib52","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1177\/0269881109348161","article-title":"The auspicious role of the 5-HT3 receptor in depression: a probable neuronal target?","volume":"24","author":"Rajkumar","year":"2010","journal-title":"J.\u00a0Psychopharmacol."},{"issue":"2","key":"10.1016\/j.neuropharm.2018.02.020_bib53","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s002130050555","article-title":"Antidepressant behavioral effects by dual inhibition of monoamine reuptake in the rat forced swimming test","volume":"136","author":"Reneric","year":"1998","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2018.02.020_bib54","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.neuropharm.2016.04.023","article-title":"Involvement of 5-HT3 receptors in the action of vortioxetine in rat brain: focus on glutamatergic and GABAergic neurotransmission","volume":"108","author":"Riga","year":"2016","journal-title":"Neuropharmacology"},{"issue":"11","key":"10.1016\/j.neuropharm.2018.02.020_bib55","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1176\/ajp.2006.163.11.1905","article-title":"Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report","volume":"163","author":"Rush","year":"2006","journal-title":"Am. J. Psychiatr."},{"issue":"4","key":"10.1016\/j.neuropharm.2018.02.020_bib56","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1023\/A:1006986824213","article-title":"Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding","volume":"19","author":"Sanchez","year":"1999","journal-title":"Cell. Mol. Neurobiol."},{"issue":"13","key":"10.1016\/j.neuropharm.2018.02.020_bib57","doi-asserted-by":"crossref","first-page":"6032","DOI":"10.1073\/pnas.92.13.6032","article-title":"Inhibitory influence of frontal cortex on locus coeruleus neurons","volume":"92","author":"Sara","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2018.02.020_bib58","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1113\/jphysiol.1979.sp012628","article-title":"Serotonergic innervation of the locus coeruleus from the dorsal raphe and its action on responses to noxious stimuli","volume":"286","author":"Segal","year":"1979","journal-title":"J.\u00a0Physiol."},{"issue":"1","key":"10.1016\/j.neuropharm.2018.02.020_bib59","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/(SICI)1096-9861(19960129)365:1<56::AID-CNE5>3.0.CO;2-I","article-title":"Dendrites of locus coeruleus neurons extend preferentially into two pericoerulear zones","volume":"365","author":"Shipley","year":"1996","journal-title":"J.\u00a0Comp. Neurol."},{"issue":"2","key":"10.1016\/j.neuropharm.2018.02.020_bib60","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0301-0082(98)00039-2","article-title":"Release of neurotransmitters in the locus coeruleus","volume":"56","author":"Singewald","year":"1998","journal-title":"Prog. Neurobiol."},{"issue":"4","key":"10.1016\/j.neuropharm.2018.02.020_bib61","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/j.1476-5381.1995.tb14990.x","article-title":"Increase of noradrenaline release in the hypothalamus of freely moving rat by postsynaptic 5-hydroxytryptamine1A receptor activation","volume":"115","author":"Suzuki","year":"1995","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.neuropharm.2018.02.020_bib62","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1124\/jpet.102.033282","article-title":"Effects of serotonin (5-hydroxytryptamine, 5-HT) reuptake inhibition plus 5-HT(2A) receptor antagonism on the firing activity of norepinephrine neurons","volume":"302","author":"Szabo","year":"2002","journal-title":"J.\u00a0Pharmacol. Exp. Therapeut."},{"issue":"1","key":"10.1016\/j.neuropharm.2018.02.020_bib63","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0006-8993(01)03121-3","article-title":"Functional and pharmacological characterization of the modulatory role of serotonin on the firing activity of locus coeruleus norepinephrine neurons","volume":"922","author":"Szabo","year":"2001","journal-title":"Brain Res."},{"issue":"9","key":"10.1016\/j.neuropharm.2018.02.020_bib64","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.euroneuro.2011.07.018","article-title":"The size and burden of mental disorders and other disorders of the brain in europe 2010","volume":"21","author":"Wittchen","year":"2011","journal-title":"Eur. Neuropsychopharmacol"},{"issue":"6","key":"10.1016\/j.neuropharm.2018.02.020_bib65","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1152\/jn.1999.82.6.2989","article-title":"Activation of serotonin receptors modulates synaptic transmission in rat cerebral cortex","volume":"82","author":"Zhou","year":"1999","journal-title":"J.\u00a0Neurophysiol."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390818300868?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390818300868?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T19:31:14Z","timestamp":1751398274000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390818300868"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":65,"alternative-id":["S0028390818300868"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2018.02.020","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serotonin 5-HT3 receptor antagonism potentiates the antidepressant activity of citalopram","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2018.02.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}